Gagandeep Kang, a virologist and scientist, is known for her
interdisciplinary research in transmission, development, and prevention of
enteric infections and their sequelae in children in India.
She has been elected as a Fellow of the Royal Society (FRS),
the first Indian woman scientist to receive this honour. The FRS is the oldest
scientific institution in the world, and is dedicated to promoting excellence
in science.
Gagandeep is the Executive Director of the
Translational Health Science and Technology Institute (THSTI), Faridabad, and
is the Chairperson of the World Health Organisation (WHO) Southeast-Asia's
Immunisation Technical Advisory Group. To develop practical approaches to
support public health, she also built national rotavirus and typhoid
surveillance networks, established laboratories to support vaccine trials, and
conducted phase one-three- clinical trials of vaccines, a comprehensive
approach that has supported two WHO prequalified vaccines made by two Indian
companies. She is also investigating the complex relationships between
infection, gut function, and physical and cognitive development, and seeking to
build a stronger human immunology research in India.